Direct-from-blood bacterial testing did not shorten vancomycin duration in adults with suspected infection compared with standard blood cultures.

Despite IV Vancomycin’s Stronghold on the MRSA Antibiotic Hospital Market, Surveyed ID Specialists Report Shifting Away from IV Vancomycin to Branded Agents, Including Pfizer’s Zyvox and ...

Hospitalized children given high-dose intravenous infusions of the antibiotic vancomycin to treat drug-resistant bacterial infections face an increased risk for kidney damage -- an often reversible ...

Treating hospitalized children with the widely used combination antibiotic therapy of intravenous vancomycin hydrochloride and piperacillin-tazobactam (TZP) significantly increases their risk for ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Intraosseous vancomycin infusion during total hip arthroplasty was feasible for timely delivery of ...

Back-to-back papers in the June 5th issue of New England Journal of Medicine reported positive phase 3 clinical trial results for two new intravenous antibiotics in the treatment of nasty bacterial ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Efficacy of once-weekly intravenous ...

January 5, 2024 – Englewood, Colorado, Leiters Health is voluntarily recalling 33 lots of products listed below to the user level. The recalled batches of vancomycin IV bags, phenylephrine IV bags, ...

To date, the Company has not received any reports of adverse events related to this recall. Leiters Health is voluntarily recalling 33 lots of vancomycin intravenous (IV) bags, phenylephrine IV bags, ...

VANCOMYCIN is a penicillinase-resistant antibiotic that may be used in the treatment of staphylococcal infections. Because it is known to be excreted chiefly through the kidneys in normal persons 1 ...